Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewIodophenpropit dihydrobromide
Discontinued Product
0779 has been discontinued.
View all Histamine H<sub>3</sub> Receptors products.
Description: Potent, selective H3 antagonist
Chemical Name: N-[2-(4-Iodophenyl)ethyl]-S-[3-(4(5)-imidazolyl)propyl]isothiourea dihydrobromide
Purity: ≥98% (HPLC)
Biological Activity for Iodophenpropit dihydrobromide
Iodophenpropit dihydrobromide is a selective H3 antagonist with high affinity (KD = 0.3 nM).
Licensing Information
Sold with the permission of SCI, Amsterdam
Technical Data for Iodophenpropit dihydrobromide
| M. Wt | 576.13 |
| Formula | C15H19IN4S.2HBr |
| Storage | Desiccate at +4°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 145196-87-8 |
| PubChem ID | 24978528 |
| InChI Key | BOSOGNBLIWPCMS-UHFFFAOYSA-N |
| Smiles | Br.Br.IC1=CC=C(CCNC(=N)SCCCC2=CNC=N2)C=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for Iodophenpropit dihydrobromide
References for Iodophenpropit dihydrobromide
References are publications that support the biological activity of the product.
Jansen et al (1992) The first radiolabelled histamine H3 receptor antagonist, [125I]iodophenpropit: saturable and reversible binding to rat cortex membranes. Eur.J.Pharmacol. 217 203 PMID: 1330590
Jansen et al (1994) Characterisation of the binding of the first selective radiolabelled histamine H3 receptor antagonist, [125I]-iodophenpropit, to rat brain. Br.J.Pharmacol. 113 355 PMID: 7834183
Menge et al (1992) Synthesis of S-[3-(4(5)-imidazolyl)propyl]-N-[2-(4-[125I]-iodophenylethyl]isothiourea sulfate [125I]-iodophenpropit), a new probe for histamine H3 receptor binding sites. J.Labelled Comp.Radiopharm. XXXI 10 781
Shahid et al (2009) Histamine, histamine receptors, and their role in immunomodulation: An updated systematic review. Open Immunol.J. 2 9
View Related Products by Target
View Related Products by Product Action
Keywords: Iodophenpropit dihydrobromide, Iodophenpropit dihydrobromide supplier, Potent, selective, H3, antagonists, Receptors, Histamine, histaminergic, 0779, Tocris Bioscience
2 Citations for Iodophenpropit dihydrobromide
Citations are publications that use Tocris products. Selected citations for Iodophenpropit dihydrobromide include:
Spaethling et al (2014) Serotonergic neuron regulation informed by in vivo single-cell transcriptomics. Toxins (Basel) 28 771 PMID: 24192459
Otvos et al (2015) Development of Plate Reader and On-Line Microfluidic Screening to Identify Ligands of the 5-Hydroxytryptamine Binding Protein in Venoms. BMC Neurosci 7 2336 PMID: 26114334
Reviews for Iodophenpropit dihydrobromide
There are currently no reviews for this product. Be the first to review Iodophenpropit dihydrobromide and earn rewards!
Have you used Iodophenpropit dihydrobromide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Histamine Receptors Scientific Review
Written by Iwan de Esch and Rob Leurs, this review provides a synopsis of the different histamine receptor subtypes and the ligands that act upon them; compounds available from Tocris are listed.
Alzheimer's Disease Poster
Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.